Caregiver Burden Associated with Behavioral and Psychological Symptoms of Dementia in Elderly People in the Local Community

Overview

Journal Dement Geriatr Cogn Disord

Publisher Karger

Specialties Geriatrics
Neurology
Psychiatry

Date 2007 Feb 15

PMID 17299264

Citations 57

Authors

Naomi Matsumoto

Manabu Ikeda

Ryuji Fukuhara

Shunichiro Shinagawa

Tomohisa Ishikawa

Takaaki Mori

Yasutaka Toyota

Teruhisa Matsumoto

Hiroyoshi Adachi

Nobutsugu Hirono

Hirotaka Tanabe

Affiliations

Soon will be listed here.

Abstract

Background: Despite many studies about the association between caregiver burden and behavioral and psychological symptoms of dementia (BPSD), there have been no population-based studies to evaluate caregiver burden associated with each BPSD.

Objective: To evaluate caregiver burden associated with the individual BPSD in elderly people living in the community.

Methods: The subjects were 67 participants with dementia living with their caregivers (diagnosed in the third Nakayama study): 51 Alzheimer's disease, 5 vascular dementia and 11 other. The Neuropsychiatric Inventory (NPI) and NPI Caregiver Distress Scale (NPI-D) were used to assess subjects' BPSD and related caregiver distress, respectively.

Results: In the subjects exhibiting BPSD, aberrant motor behavior had the highest mean NPI score, and depression/dysphoria had the lowest. Agitation/aggression had the highest mean NPI-D score, and euphoria/elation had the lowest. Delusion, agitation/aggression, apathy/indifference, irritability/lability and aberrant motor behavior showed a correlation between the NPI and NPI-D scores.

Conclusion: The burden associated with BPSD is different for each symptom and does not always depend on frequency and severity of BPSD. These findings suggest that some symptoms, such as agitation/aggression and irritability/lability, may affect the caregivers significantly, although their frequency and severity are low.

Citing Articles

Behavioral and psychological symptoms and brain volumes in community-dwelling older persons from the Nakayama Study.

Tachibana A, Iga J, Ozaki T, Yoshino Y, Yamazaki K, Ochi S Sci Rep. 2024; 14(1):26097.

PMID: 39478058 PMC: 11525632. DOI: 10.1038/s41598-024-77477-5.

Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer Disease.

Schaffer Aguzzoli C, Ferreira P, Povala G, Ferrari-Souza J, Bellaver B, Soares Katz C JAMA Netw Open. 2023; 6(11):e2345175.

PMID: 38010651 PMC: 10682836. DOI: 10.1001/jamanetworkopen.2023.45175.

Burden in caregivers of primary care patients with dementia: influence of neuropsychiatric symptoms according to disease stage (NeDEM project).

Garcia-Martin V, de Hoyos-Alonso M, Delgado-Puebla R, Ariza-Cardiel G, Del Cura-Gonzalez I BMC Geriatr. 2023; 23(1):525.

PMID: 37644410 PMC: 10463529. DOI: 10.1186/s12877-023-04234-0.

White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases.

Ozzoude M, Varriano B, Beaton D, Ramirez J, Adamo S, Holmes M Alzheimers Res Ther. 2023; 15(1):114.

PMID: 37340319 PMC: 10280981. DOI: 10.1186/s13195-023-01257-y.

Characterizing PRN Use of Psychotropic Medications for Acute Agitation in Canadian Long-Term Care Residents with Dementia Before and During COVID-19.

Wang H, Kusumo R, Kiss A, Tennen G, Marotta G, Viaje S J Alzheimers Dis Rep. 2023; 7(1):575-587.

PMID: 37313488 PMC: 10259051. DOI: 10.3233/ADR-230009.